René Rückert
Operationeel Directeur bij Isarna Therapeutics GmbH
Actieve functies van René Rückert
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Isarna Therapeutics GmbH
 Isarna Therapeutics GmbH BiotechnologyHealth Technology Isarna Therapeutics GmbH engages in developing selective TGF-ß inhibitors. It works on a pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcome. The company focuses on biopharmaceutical research, pipeline development, and partnering and licensing programs. Isarna Therapeutics was founded by Karl-Hermann Schlingensiepen and Reimar Schlingensiepen in 1998 and is headquartered in Munich, Germany. | Operationeel Directeur | 01-01-2019 | - |
| Hoofd Techniek/Wetenschap/O&O | 01-01-2018 | 01-01-2019 |
Loopbaan van René Rückert
Opleiding van René Rückert
| Charité - Universitätsmedizin Berlin | Doctorate Degree |
| Warwick Business School | Masters Business Admin |
Statistieken
Internationaal
| Duitsland | 3 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Isarna Therapeutics GmbH
Isarna Therapeutics GmbH BiotechnologyHealth Technology Isarna Therapeutics GmbH engages in developing selective TGF-ß inhibitors. It works on a pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcome. The company focuses on biopharmaceutical research, pipeline development, and partnering and licensing programs. Isarna Therapeutics was founded by Karl-Hermann Schlingensiepen and Reimar Schlingensiepen in 1998 and is headquartered in Munich, Germany. | Health Technology |
- Beurs
- Insiders
- René Rückert
- Ervaring
